This article is more than 5 years old. Information may no longer be current.

AMO receives FDA clearance for fifth-generation femtosecond laser

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA ANA, Calif. — Advanced Medical Optics has received U.S. Food and Drug Administration clearance for its fifth-generation IntraLase femtosecond laser, the company announced in a press release.

The fifth-generation model — called the iFS advanced femtosecond laser — is capable of creating a corneal flap in less than 10 seconds and features an inverted bevel-in side cut angle designed to enhance flap lift, increase postoperative flap adhesion and improve the biomechanical stability of the cornea. The laser is also capable of performing fully customized IntraLase-enabled keratoplasty, the release said.

Compared with prior models, the fifth-generation platform features a faster repetition rate, tighter spot separation, lower energy, a high-resolution digital video microscope and a newly designed user interface.

The model is also ergonomically designed to improve surgeon comfort, the release said.

The iFS advanced femtosecond laser is currently available for order and will begin shipping to surgeons in the United States later this year, according to the release.